Status:
WITHDRAWN
Evaluation of A Partially Hydrolyzed in Improving FGIDs Symptoms
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Functional Gastrointestinal Disorders
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
Evaluation of A Partially Hydrolyzed Whey Protein Infant Formula in Improving Functional Gastrointestinal Disorders (FGIDs) Symptoms
Detailed Description
This study will investigate the prevalence of Shanghai area's infant with FGIDs symptom and contrast for the FGIDs symptoms by using different intervention means, and evaluate the effectiveness of FGI...
Eligibility Criteria
Inclusion
- Infants is formula-fed or mixed feeding a cow milk protein-based formula for less 7 days prior to enrollment.
- Infant is between 30-180 days of age.
- Infant's parent(s) or Legally authorized representative(LAR) has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.
Exclusion
- Complementary food was added for infants or parents are willing to add complementary food during study.
- Suffer from infection/illness.
- Infant has suspected or known metabolic or physical diseases affecting infant feeding and/or metabolism.
- Infant has visible bloody stools (detected before enrollment) prior to enrollment.
- Participation in another study.
Key Trial Info
Start Date :
July 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03390309
Start Date
July 5 2018
End Date
June 28 2019
Last Update
July 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.